Introduction of the beta1-4
N-acetylglucosaminyltransferase (GnT-III) gene was reported to suppress
metastasis in highly metastatic B16-hm murine
melanoma cells (Yoshimura, M., Nishikawa, A. , Ihara, Y., Taniguchi, S., and Taniguchi, N.(1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8754-8758). In this study, the effect of GnT-III gene transfer on
E-cadherin was studied, since
E-cadherin acts as a suppressor of
metastasis.
E-cadherin expression at cell-cell contacts of B16-hm cells expressing high GnT-III activity was greater than controls without affecting transcription.
Lectin blotting showed that
E-cadherin from GnT-III transfectants was glycosylated by ectopically expressed GnT-III. The glycosylated
E-cadherin exhibited the delayed turnover and the decreased release from cell surface, as compared with the native
E-cadherin, resulting in the elevated expression at the cell-cell border of GnT-III transfectants. Furthermore, cell-cell aggregation was enhanced in GnT-III transfectants, indicating that the glycosylated
E-cadherin is biologically functional. These results suggest that the glycosylated
E-cadherin contributes to the suppression of
metastasis by the introduction of GnT-III gene into
melanoma cells.